Rheumatoid Arthritis Clinical Trial

About This Study

This clinical trial is evaluating an investigational biologic medication designed to help patients with rheumatoid arthritis (RA) who haven't achieved adequate disease control with current treatments. The study aims to determine whether this new therapy can reduce joint inflammation, slow disease progression, and improve overall quality of life.

Rheumatoid arthritis is an autoimmune disease that causes chronic inflammation of the joints, leading to pain, swelling, stiffness, and potential joint damage over time. For many patients, existing treatments don't provide sufficient relief or may cause unwanted side effects.

Learn more about rheumatoid arthritis at Overlake Arthritis →

Who May Qualify?

You may be eligible for this study if you:

• Have been diagnosed with rheumatoid arthritis by a rheumatologist
• Have moderate to severe disease activity despite current treatment
• Have tried at least one DMARD (like methotrexate) or biologic medication
• Are between 18 and 75 years old
• Are willing to attend study visits over approximately 12 months

Not sure if you qualify? Complete our quick eligibility screening below. It takes less than 2 minutes.

What Participation Involves

• Screening Visit: Medical history, physical exam, blood tests, and joint assessment
• Study Visits: Approximately 10-12 clinic visits over 12 months
• Study Medication: Investigational biologic therapy administered as injection or infusion
• Monitoring: Regular blood tests, joint assessments, and health questionnaires
• Follow-up: Safety monitoring after study completion

Compensation

Qualified participants will receive compensation for their time and travel expenses. All study-related medications, tests, and procedures are provided at no cost.

Check Your Eligibility

Answer a few quick questions to see if you may qualify. This screening is completely confidential.